EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) kicked off on Friday, up 7.21% from the previous trading day, before settling in for the closing price of $12.21. Over the past 52 weeks, EYPT has traded in a range of $3.91-$14.91.
Healthcare Sector giant saw their annual sales surged by 15.65% over the last five years. While this was happening, its average annual earnings per share was recorded -29.54%. With a float of $60.48 million, this company’s outstanding shares have now reached $68.89 million.
The firm has a total of 165 workers. Let’s measure their productivity.
EyePoint Pharmaceuticals Inc (EYPT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of EyePoint Pharmaceuticals Inc is 12.25%, while institutional ownership is 90.04%. The most recent insider transaction that took place on May 19 ’25, was worth 29,950. In this transaction Director of this company bought 5,000 shares at a rate of $5.99, taking the stock ownership to the 36,500 shares. Before that another transaction happened on May 16 ’25, when Company’s Director bought 5,000 for $5.81, making the entire transaction worth $29,050. This insider now owns 31,500 shares in total.
EyePoint Pharmaceuticals Inc (EYPT) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.54 earnings per share (EPS), higher than consensus estimate (set at -0.54) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.75 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -29.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.62% during the next five years compared to 15.65% growth over the previous five years of trading.
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Trading Performance Indicators
Take a look at EyePoint Pharmaceuticals Inc’s (EYPT) current performance indicators. Last quarter, stock had a quick ratio of 7.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.68, a number that is poised to hit -0.77 in the next quarter and is forecasted to reach -3.02 in one year’s time.
Technical Analysis of EyePoint Pharmaceuticals Inc (EYPT)
Analysing the last 5-days average volume posted by the [EyePoint Pharmaceuticals Inc, EYPT], we can find that recorded value of 1.19 million was better than the volume posted last year of 0.89 million. As of the previous 9 days, the stock’s Stochastic %D was 74.24%.
During the past 100 days, EyePoint Pharmaceuticals Inc’s (EYPT) raw stochastic average was set at 73.89%, which indicates a significant decrease from 82.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.77 in the past 14 days, which was higher than the 0.74 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.84, while its 200-day Moving Average is $9.00. Now, the first resistance to watch is $13.50. This is followed by the second major resistance level at $13.91. The third major resistance level sits at $14.70. If the price goes on to break the first support level at $12.30, it is likely to go to the next support level at $11.51. Now, if the price goes above the second support level, the third support stands at $11.10.
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Key Stats
The company with the Market Capitalisation of 902.26 million has total of 68,927K Shares Outstanding. Its annual sales at the moment are 43,270 K in contrast with the sum of -130,870 K annual income. Company’s last quarter sales were recorded 5,330 K and last quarter income was -59,430 K.
